Alzheimer’s Association International Conference | July 28 – Aug. 1, 2024 | Philadelphia, USA, and Online

Continuing Education

Continuing education credits are jointly provided by Postgraduate Institute for Medicine (PIM) and the Alzheimer’s Association. CME is free for ISTAART members and available to non-ISTAART members for $100. Learn more about becoming an ISTAART member.

More information about AAIC 2024 continuing education credit will be available in the coming months.

Contact the Postgraduate Institute for Medicine (PIM) for questions about CE credits at

On This Page:

Target Audience

This activity is intended for biochemists, geriatric psychiatrists, geriatric specialists, molecular and cell biologists, neurologists, neuroscientists, nurses, pharmacologists, primary care physicians, psychiatrists, psychologists and radiologists involved in the research and/or care of people with Alzheimer’s and other dementias.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Utilize advances in technology, including imaging and biomarkers to improve diagnosis and monitor disease progression in Alzheimer’s disease.
  • Review data on current animal models for Alzheimer's disease.
  • Compare the pathophysiology of aging, Alzheimer's disease and other geriatric syndromes.
  • Identify potential targets for treatment of Alzheimer's disease.
  • Discuss recommendations for the prevention of Alzheimer's disease.
  • Explain therapeutic breakthroughs in neurodegenerative disease.
  • Identify emerging strategies likely to drive future advances in Alzheimer's disease.
  • Describe the impact of Alzheimer's on individuals with the disease and their caregivers.
  • Indicate how Alzheimer's disease affects society as it relates to health economics.

Faculty: Wiesje van der Flier and Sebastian Palmqvist of the AAIC Scientific Program Committee.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine (PIM) and the Alzheimer’s Association. PIM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Disclosure of Conflicts of Interest

PIM requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

A copy of the Speaker Disclosure of Conflicts of Interest report will be available on the resource tab of the AAIC virtual platform.

The Alzheimer’s Association and PIM planners and others have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration (FDA). The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.

How to Claim Credit

The certificate of attendance will be complimentary for both the virtual and in-person conference formats.


Advance Your Career

Join ISTAART, an inclusive global network of scientists, clinicians and dementia professionals. With newly discounted rates and free memberships for students, it’s easier than ever to become a part of ISTAART.

Learn More

Join the Conversation #AAIC24

We use cookies to improve your experience on this website. Learn about options for managing your personal data in our Privacy Policy.